Acute Erythroid Leukemia: Clinical Trials

1 trial for Acute Erythroid Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Acute Erythroid Leukemia: new trials by email Literature Review of Acute Erythroid Leukemia trials Research Report on Acute Erythroid Leukemia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers
Fludarabine, Cyclophosphamide, Thiotepa - Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia
Phase 2TerminatedFred Hutchinson Cancer Center12022-10-062025-01-01

Narrower conditions

Anemia, Refractory (1)  ·  Anemia, Refractory, with Excess of Blasts (1)  ·  HIV Infections (1)  ·  Hematologic Neoplasms (1)  ·  Leukemia, Erythroblastic, Acute (1)  ·  Leukemia, Megakaryoblastic, Acute (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Myelodysplastic Syndromes (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Anemia (1)  ·  Blood-Borne Infections (1)  ·  Bone Marrow Diseases (1)  ·  Chronic Disease (1)  ·  Communicable Diseases (1)  ·  Disease Attributes (1)  ·  Genital Diseases (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Immunoproliferative Disorders (1)  ·  Infections (1)  ·  Lentivirus Infections (1)  ·  Leukemia (1)

Interventions

Cord Blood Stem Cell Transplantation (1)  ·  Cyclophosphamide (1)  ·  Thiotepa (1)  ·  Whole-Body Irradiation (1)  ·  fludarabine (1)  ·  fludarabine phosphate (1)

Sponsors

Fred Hutchinson Cancer Center (1)

Countries

United States (1)

Top investigators

Filippo Milano (1)

NIH funding

R34HL142322 (1)